(Q53251811)
Statements
Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin (English)
E Ruether
X A Alvarez
M Rainer